Boothbay Fund Management, LLC 180 Life Sciences Corp. Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$3.27 - $6.38 $201,353 - $392,854
-61,576 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$5.11 - $10.81 $2.13 Million - $4.51 Million
-416,897 Reduced 87.13%
61,576 $333,000
Q1 2021

May 17, 2021
BUY
$2.51 - $6.96 $1.2 Million - $3.33 Million
478,473 New
478,473 $3.14 Million

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $141M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email